Biodexa Pharmaceuticals (BDRX) Operating Margin (2015 - 2021)
Biodexa Pharmaceuticals (BDRX) posted Operating Margin of 288000.0% for Q4 2020, down 25.59% sequentially from 229312.5% in Q3 2020, and down 28307913.0% YoY from N/an in Q1 2020.
Biodexa Pharmaceuticals (BDRX) Operating Margin (2015 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported Operating Margin for 4 years, with the latest figure at 288000.0% in Q4 2020.
- Quarterly Operating Margin fell 28307913.0% year-over-year to 288000.0% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 6506.98% (changed N/A YoY) and the FY2023 annual result came in at 2103.41%, down 82559.0% from the prior year.
- Operating Margin retreated to 288000.0% in Q4 2020 per BDRX's latest filing, from 229312.5% in the prior quarter.
- Over five years, Operating Margin peaked at 1666.84% in Q4 2016 and troughed at 288000.0% in Q4 2020.
- A 3-year average of 130975.05% and a median of 117116.68% in 2019 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2016 and 2020: Operating Margin slumped 118713 bps in 2016, then tumbled 28307913 bps in 2020.
- Over 3 years, Operating Margin stood at 1666.84% in 2016, then tumbled by 195 bps to 4920.87% in 2019, then tumbled by 5753 bps to 288000.0% in 2020.
- According to Business Quant data, Operating Margin over the past three periods registered 288000.0%, 229312.5%, and 4920.87% for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -806.48% |
| Dec 31, 2020 | -288,000.00% |
| Sep 10, 2020 | -229,312.50% |
| Dec 31, 2019 | -4,920.87% |
| Dec 31, 2016 | -1,666.84% |
| Dec 31, 2015 | -479.71% |